T. Rowe Price Investment Management’s Karyopharm Therapeutics KPTI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$3.14M Buy
728,766
+589,120
+422% +$2.54M ﹤0.01% 589
2025
Q1
$523K Buy
+139,646
New +$523K ﹤0.01% 633